Northwest Biotherapeutics (NWBO) Reports Q3 Loss of $0.35/Share
Tweet
Share
E-mailGet Alerts NWBO Hot Sheet
Price: $0.19 --0%
Financial Fact:
Research and development: 21.09M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
Research and development: 21.09M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Northwest Biotherapeutics (NASDAQ: NWBO) reported Q3 EPS of ($0.35), versus ($0.65) reported last year. Revenue for the quarter came in at $582 thousand, versus $400 thousand reported last year.
For earnings history and earnings-related data on Northwest Biotherapeutics (NWBO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Bristow Group to acquire Berry Aviation for $105 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
